We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

136 hedge funds and large institutions have $338M invested in Sanofi Contingent Value Rights in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $324M → $338M (+$13.8M)

7% less funds holding

Funds holding: 146 → 136 (-10)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

40% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 35

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

Holders
136
Holders Change
-10
Holders Change %
-6.85%
% of All Funds
4.41%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.13%
New
7
Increased
21
Reduced
35
Closed
17
Calls
$1.01M
Puts
–
Net Calls
+$1.01M
Net Calls Change
+$1.01M

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$6.72M
2
MCM
Mason Capital Management
New York
+$5.99M
3
WA
Whitebox Advisors
Minnesota
+$2.25M
4
DI
Dalton Investments
Nevada
+$1.24M
5
SC
Sophrosyne Capital
New York
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
TCA
Taconic Capital Advisors
New York
-$5.79M
2
RCM
Royal Capital Management
New York
-$3.55M
3
FCM
Farallon Capital Management
California
-$2.51M
4
BlackRock
BlackRock
New York
-$2.27M
5
PCM
Pentwater Capital Management
Florida
-$1.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
U
51
UBS
Switzerland
$242K +$54.7K +28,725 +32%
KAM
52
Knightsbridge Asset Management
California
$238K – – –
BCM
53
Basso Capital Management
Connecticut
$222K – – –
ZIG
54
Zuckerman Investment Group
Illinois
$214K – – –
Neuberger Berman Group
55
Neuberger Berman Group
New York
$200K – – –
DMK
56
David M. Knott
$186K – – –
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$175K +$71.5K +37,536 +77%
TPM
58
T2 Partners Management
New York
$164K +$59.2K +31,100 +62%
CCA
59
Catalyst Capital Advisors
New York
$162K – – –
CAS
60
CTC Alternative Strategies
Illinois
$153K -$190 -100 -0.1%
Wells Fargo
61
Wells Fargo
California
$144K -$145 -76 -0.1%
WCM
62
Waterstone Capital Management
Minnesota
$143K -$194K -101,610 -59%
IRF
63
IBM Retirement Fund
New York
$140K – – –
ACA
64
Anchor Capital Advisors
Massachusetts
$127K – – –
DAM
65
Deltec Asset Management
New York
$119K – – –
Brown Advisory
66
Brown Advisory
Maryland
$105K – – –
Korea Investment Corp
67
Korea Investment Corp
South Korea
$100K – – –
OCM
68
Osterweis Capital Management
California
$84K – – –
PCM
69
Prelude Capital Management
New York
$83K – – –
DBG
70
De Burlo Group
Massachusetts
$81K -$190 -100 -0.2%
WHI
71
William Harris Investors
Illinois
$65K – – –
FCH
72
Freestone Capital Holdings
Washington
$54K +$24K +12,625 +66%
OC
73
Oppenheimer & Co
New York
$53K -$688 -361 -1%
RP
74
Reinhart Partners
Wisconsin
$40K +$38.1K +20,000 New
BIA
75
Biondo Investment Advisors
Pennsylvania
$36K -$809 -425 -2%
1 2
3
4 5

GCVRZ Hedge Fund Activity: Q3 2013 in Review

136 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2013, worth a combined $338M — up 4.3% from $324M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of GCVRZ and 7 opened new positions — a net loss of 10 holders — while 35 trimmed existing stakes and 21 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $6.72M. The largest seller was Taconic Capital Advisors, exiting entirely with an estimated $5.79M sold.

  • 136 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2013, down from 146 in Q2 2013.
  • Funds reported $338M of Sanofi Contingent Value Rights stock for Q3 2013, up 4.3% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q3 2013 and 17 closed out, a net change of -10 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2013 was Fir Tree Capital Management, an estimated $6.72M added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2013 was Taconic Capital Advisors, an estimated $5.79M sold.

Based on aggregated 13F filings for Q3 2013.